Daily pill shrinks pancreatic cancer tumours in early trial
· World · BBC News, Financial Times
A daily pill called daraxonrasib, combined with chemotherapy, shrank or eliminated tumours in one in 12 advanced pancreatic cancer patients during early trials. In the 61 participants with recently diagnosed, metastasized disease, tumours stopped growing in nearly all and shrank in over 60%. The treatment, a KRAS inhibitor already approved in the US, targets mutations driving most pancreatic cancers and may extend survival. Doctors caution it is not a cure and longer studies are needed to confirm remission and durability of response.
Why it matters
This breakthrough offers new hope for patients with the deadliest common cancer in the UK, potentially extending survival beyond the current months-long prognosis of advanced disease.
Read the original report — BBC News
Join us on Telegram
Breaking news the moment it lands. At 10,000 members we ship the Android app.